Smith Group Asset Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-33,235
Closed -$526K 347
2021
Q4
$526K Sell
33,235
-828
-2% -$14.1K 0.02% 145
2021
Q3
$664K Sell
34,063
-520
-2% -$10.3K 0.03% 115
2021
Q2
$787K Sell
34,583
-323
-0.9% -$6.7K 0.04% 93
2021
Q1
$641K Buy
34,906
+19,019
+120% +$312K 0.03% 113
2020
Q4
$237K Sell
15,887
-37
-0.2% -$483 0.01% 171
2020
Q3
$179K Sell
15,924
-38
-0.2% -$374 0.01% 172
2020
Q2
$127K Sell
15,962
-148
-0.9% -$1.23K 0.01% 184
2020
Q1
$130K Sell
16,110
-37
-0.2% -$440 0.01% 191
2019
Q4
$203K Buy
+16,147
New +$174K 0.01% 197

Other funds holding SEM

Smith Group Asset Management's SEM Position: Q1 2022 in Review

Smith Group Asset Management sold out of Select Medical (SEM) in Q1 2022, closing a stake of 33,235 shares — an estimated $526K sold.

Smith Group Asset Management first reported a position in SEM in Q4 2019 and held it in 9 quarters. The position peaked at $787K in Q2 2021. 240 funds tracked by Wall St. Rank hold SEM as of Q1 2022.

  • Smith Group Asset Management reported no remaining Select Medical position as of Q1 2022 after selling out during the quarter.
  • Smith Group Asset Management sold 33,235 Select Medical shares in Q1 2022, an estimated $526K.
  • Smith Group Asset Management first reported a position in Select Medical in Q4 2019 and held it in 9 quarters.
  • Smith Group Asset Management's Select Medical position peaked at $787K in Q2 2021.
  • 240 funds tracked by Wall St. Rank held Select Medical as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.